(VRSN) VeriSign - Overview
Stock: Domain Registry, Root Zone Maintainer, DNS Resolution
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.87% |
| Yield on Cost 5y | 1.16% |
| Yield CAGR 5y | % |
| Payout Consistency | 13.7% |
| Payout Ratio | 35.1% |
| Risk 5d forecast | |
|---|---|
| Volatility | 41.0% |
| Relative Tail Risk | -7.34% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.08 |
| Alpha | -6.18 |
| Character TTM | |
|---|---|
| Beta | 0.385 |
| Beta Downside | 0.332 |
| Drawdowns 3y | |
|---|---|
| Max DD | 26.35% |
| CAGR/Max DD | 0.09 |
Description: VRSN VeriSign December 17, 2025
VeriSign Inc. (NASDAQ: VRSN) operates core internet infrastructure, maintaining two of the 13 global DNS root servers and serving as the exclusive registry for the .com and .net TLDs, which together account for roughly 45 % of all registered domain names worldwide. The firm also runs the .name and .cc directories and provides back-end services for .edu, underpinning a large share of e-commerce and online communications. Incorporated in 1995 and headquartered in Reston, Virginia, VeriSign is classified under the “Internet Services & Infrastructure” GICS sub-industry.
Key quantitative touchpoints (as of FY 2024):
• Revenue of $1.9 billion, with a 13 % year-over-year increase driven largely by higher .com registration fees and growth in security-related services (e.g., DNS SEC, Managed DNS).
• Operating margin consistently above 70 %, reflecting the high-margin, recurring-revenue nature of domain-registry contracts.
• Domain-portfolio concentration risk: .com and .net together generate > 80 % of net revenue, making the business sensitive to shifts in global e-commerce activity and corporate branding strategies.
• Sector drivers: accelerating digital transformation, rising demand for cybersecurity-enhanced DNS services, and the long-term scarcity of premium domain names support pricing power and modest organic growth.
For a deeper quantitative view, you might explore ValueRay’s analyst dashboard for VRSN to see how these fundamentals compare against peers and market expectations.
Piotroski VR‑10 (Strict, 0-10) 8.0
| Net Income: 811.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.72 > 0.02 and ΔFCF/TA 13.35 > 1.0 |
| NWC/Revenue: -38.03% < 20% (prev -52.44%; Δ 14.40% < -1%) |
| CFO/TA 0.74 > 3% & CFO 1.03b > Net Income 811.0m |
| Net Debt (1.55b) to EBITDA (1.16b): 1.34 < 3 |
| Current Ratio: 0.53 > 1.5 & < 3 |
| Outstanding Shares: last quarter (93.6m) vs 12m ago -3.80% < -2% |
| Gross Margin: 87.97% > 18% (prev 0.88%; Δ 8709 % > 0.5%) |
| Asset Turnover: 113.5% > 50% (prev 105.5%; Δ 8.03% > 0%) |
| Interest Coverage Ratio: 14.60 > 6 (EBITDA TTM 1.16b / Interest Expense TTM 76.9m) |
Altman Z'' -15.00
| A: -0.44 (Total Current Assets 688.4m - Total Current Liabilities 1.31b) / Total Assets 1.40b |
| B: -8.54 (Retained Earnings -11.98b / Total Assets 1.40b) |
| C: 0.78 (EBIT TTM 1.12b / Avg Total Assets 1.43b) |
| D: -0.59 (Book Value of Equity -2.05b / Total Liabilities 3.45b) |
| Altman-Z'' Score: -26.08 = D |
Beneish M -3.43
| DSRI: 0.67 (Receivables 11.2m/15.8m, Revenue 1.63b/1.54b) |
| GMI: 1.00 (GM 87.97% / 87.58%) |
| AQI: 0.99 (AQ_t 0.35 / AQ_t-1 0.35) |
| SGI: 1.05 (Revenue 1.63b / 1.54b) |
| TATA: -0.16 (NI 811.0m - CFO 1.03b) / TA 1.40b) |
| Beneish M-Score: -3.43 (Cap -4..+1) = AA |
What is the price of VRSN shares?
Over the past week, the price has changed by -8.21%, over one month by -8.95%, over three months by -6.15% and over the past year by +2.70%.
Is VRSN a buy, sell or hold?
- StrongBuy: 2
- Buy: 0
- Hold: 1
- Sell: 0
- StrongSell: 1
What are the forecasts/targets for the VRSN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 290.8 | 29.7% |
| Analysts Target Price | 290.8 | 29.7% |
| ValueRay Target Price | 225.3 | 0.5% |
VRSN Fundamental Data Overview February 05, 2026
P/E Forward = 25.0
P/S = 13.9863
P/EG = 2.7696
Revenue TTM = 1.63b USD
EBIT TTM = 1.12b USD
EBITDA TTM = 1.16b USD
Long Term Debt = 1.79b USD (from longTermDebt, last quarter)
Short Term Debt = 6.00m USD (from shortTermDebt, last quarter)
Debt = 1.79b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.55b USD (from netDebt column, last quarter)
Enterprise Value = 23.92b USD (22.75b + Debt 1.79b - CCE 617.7m)
Interest Coverage Ratio = 14.60 (Ebit TTM 1.12b / Interest Expense TTM 76.9m)
EV/FCF = 23.80x (Enterprise Value 23.92b / FCF TTM 1.01b)
FCF Yield = 4.20% (FCF TTM 1.01b / Enterprise Value 23.92b)
FCF Margin = 61.79% (FCF TTM 1.01b / Revenue TTM 1.63b)
Net Margin = 49.86% (Net Income TTM 811.0m / Revenue TTM 1.63b)
Gross Margin = 87.97% ((Revenue TTM 1.63b - Cost of Revenue TTM 195.7m) / Revenue TTM)
Gross Margin QoQ = 88.36% (prev 88.02%)
Tobins Q-Ratio = 17.04 (Enterprise Value 23.92b / Total Assets 1.40b)
Interest Expense / Debt = 1.06% (Interest Expense 18.9m / Debt 1.79b)
Taxrate = 21.68% (58.9m / 271.7m)
NOPAT = 879.1m (EBIT 1.12b * (1 - 21.68%))
Current Ratio = 0.53 (Total Current Assets 688.4m / Total Current Liabilities 1.31b)
Debt / Equity = -0.87 (negative equity) (Debt 1.79b / totalStockholderEquity, last quarter -2.05b)
Debt / EBITDA = 1.34 (Net Debt 1.55b / EBITDA 1.16b)
Debt / FCF = 1.54 (Net Debt 1.55b / FCF TTM 1.01b)
Total Stockholder Equity = -1.99b (last 4 quarters mean from totalStockholderEquity)
RoA = 56.60% (Net Income 811.0m / Total Assets 1.40b)
RoE = -40.66% (negative equity) (Net Income TTM 811.0m / Total Stockholder Equity -1.99b)
RoCE = -541.7% (out of range, set to none) (EBIT 1.12b / Capital Employed (Equity -1.99b + L.T.Debt 1.79b))
RoIC = -425.7% (out of range, set to none) (NOPAT 879.1m / Invested Capital -206.5m)
WACC = 6.86% (E(22.75b)/V(24.54b) * Re(7.33%) + D(1.79b)/V(24.54b) * Rd(1.06%) * (1-Tc(0.22)))
Discount Rate = 7.33% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -4.21%
[DCF Debug] Terminal Value 83.23% ; FCFF base≈943.8m ; Y1≈1.01b ; Y5≈1.21b
Fair Price DCF = 276.5 (EV 27.18b - Net Debt 1.55b = Equity 25.63b / Shares 92.7m; r=6.86% [WACC]; 5y FCF grow 7.40% → 2.90% )
EPS Correlation: -11.69 | EPS CAGR: -43.71% | SUE: -4.0 | # QB: 0
Revenue Correlation: 99.07 | Revenue CAGR: 5.71% | SUE: 1.59 | # QB: 1
EPS next Quarter (2026-03-31): EPS=2.28 | Chg30d=+0.000 | Revisions Net=+1 | Analysts=1
EPS next Year (2026-12-31): EPS=9.53 | Chg30d=+0.042 | Revisions Net=-1 | Growth EPS=+7.6% | Growth Revenue=+3.9%